This genetic variation may influence the expression and/or regulation of several genes in the region, with the evidence pointing most strongly to FBXO28 and TP53BP2. This result may provide useful clues to the relationship between TP53 and ER signaling in breast cancer as well as to the way this interplay influences tumor progression and the outcome of the disease. Here, TP53BP2 is linked to neoplasm.